The selloff in McDermott (MDR) since missing analysts Q4 earnings estimates and reporting a weak...

|About: McDermott International, Inc. (MDR)|By:, SA News Editor

The selloff in McDermott (MDR) since missing analysts Q4 earnings estimates and reporting a weak outlook could pose a long-term buying opportunity, Barron's David Englander writes. Prospects are looking up, as MDR's pipeline of bids on new work rose to $7.7B, up 57% Y/Y. Shares trade for just 9.5x estimated 2014 EPS of $1.07, and could rise 25% in a year as new project awards roll in.